Acute Unilateral Hearing Impairment as an Indicator of Neurofibromatosis Type 2
-
September 15, 2026
Acute Unilateral Hearing Impairment as an Indicator of Neurofibromatosis Type 2
Background
Neurofibromatosis Type 2 (NF2) is an autosomal dominant genetic disorder characterized by benign tumors of the nervous system, particularly vestibular schwannomas. Early diagnosis is crucial for managing symptoms. Recognizing atypical presentations of hearing loss can lead to timely interventions.
Data Highlights
No numerical or trial data was provided in the source material.
Key Findings
- A 57-year-old man presented with acute left-sided sensorineural hearing loss.
- Initial treatment included high-dose oral steroids and tympanic steroid injections, which provided minimal improvement.
- Magnetic resonance imaging (MRI) revealed bilateral intracanalicular masses consistent with vestibular schwannomas.
- Diagnosis of NF2 was made based on imaging findings and clinical presentation.
- Referral for genetic counseling was recommended following diagnosis.
Clinical Implications
Clinicians should be vigilant for sudden-onset unilateral hearing loss as it may indicate underlying conditions such as NF2.
Conclusion
This case highlights the importance of timely diagnosis in patients presenting with acute unilateral hearing loss.
Related Resources & Content
- Acta Neuropathologica, 2019 -- Recent Insights into Central Nervous System Involvement in Neurofibromatosis Type 2
- Journal of Neuro-Oncology, 2017 -- Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
- Frontiers in Neurology, 2026 -- Case Report: Multiple sclerosis and Neurofibromatosis type 1: a rare comorbidity
- Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation - PubMed
- NF2-Related Schwannomatosis - GeneReviews® - NCBI Bookshelf
- Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2 | New England Journal of Medicine
- phoenix children's medical connection — Cerebral Vasculopathy in Neurofibromatosis Type 1: An Under-Recognized Problem?
- Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation - PubMed
- NF2-Related Schwannomatosis - GeneReviews® - NCBI Bookshelf
- Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2 | New England Journal of Medicine
Based on findings from:
Unilateral Hearing Loss Leading to a Diagnosis of Neurofibromatosis 2
Annals Of Internal Medicine: Clinical Cases, 2026.
https://www.acpjournals.org/doi/10.7326/aimcc.2026.0199
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
